Investing.com - Financial Markets Worldwide

Betta Pharmaceuticals Co Ltd (300558)

Shenzhen
Currency in CNY
70.67
+1.89(+2.75%)
Closed·
300558 Scorecard
Full Analysis
Net income is expected to grow this year
300558 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
67.7372.00
52 wk Range
33.4173.72
Key Statistics
Edit
Bid/Ask
70.64 / 70.67
Prev. Close
68.78
Open
68.49
Day's Range
67.73-72
52 wk Range
33.41-73.72
Volume
10.74M
Average Volume (3m)
12.96M
1-Year Change
99.1%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300558 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Buy
Price Target
63.16
Downside
-10.63%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 17
Impressive gross profit margins
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Betta Pharmaceuticals Co Ltd Company Profile

Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat first-line treatment of locally advanced or non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. The company was founded in 2003 and is based in Hangzhou, China.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
1961
Market
China

Compare 300558 to Peers and Sector

Metrics to compare
300558
Peers
Sector
Relationship
P/E Ratio
93.3x30.0x−0.6x
PEG Ratio
−3.660.240.00
Price/Book
5.3x3.1x2.6x
Price / LTM Sales
9.5x4.7x3.3x
Upside (Analyst Target)
−10.3%17.4%39.1%
Fair Value Upside
Unlock−0.1%5.4%Unlock

Analyst Ratings

4 Buy
0 Hold
1 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 63.16
(-10.63% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.75%
Dividend Yield
0.28%
Industry Median 1.41%
Annualised payout
0.20
Paid annually
5-Years Growth
+1.03%
Growth Streak
Unlock

Earnings

Latest Release
Aug 20, 2025
EPS / Forecast
0.39 / 0.38
Revenue / Forecast
810.00M / 904.36M
EPS Revisions
a
a
Unlock
Last 90 days

300558 Income Statement

FAQ

What Stock Exchange Does Betta Pharma Trade On?

Betta Pharma is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Betta Pharma?

The stock symbol for Betta Pharma is "300558."

What Is the Betta Pharma Market Cap?

As of today, Betta Pharma market cap is 29.73B.

What Is Betta Pharma's Earnings Per Share (TTM)?

The Betta Pharma EPS (TTM) is 0.75.

When Is the Next Betta Pharma Earnings Date?

Betta Pharma will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is 300558 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Betta Pharma Stock Split?

Betta Pharma has split 0 times.

How Many Employees Does Betta Pharma Have?

Betta Pharma has 1961 employees.

What is the current trading status of Betta Pharma (300558)?

As of 29 Aug 2025, Betta Pharma (300558) is trading at a price of 70.67, with a previous close of 68.78. The stock has fluctuated within a day range of 67.73 to 72.00, while its 52-week range spans from 33.41 to 73.72.

What Is Betta Pharma (300558) Price Target According to Analysts?

The average 12-month price target for Betta Pharma is CNY63.155, with a high estimate of CNY83 and a low estimate of CNY43.31. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -10.63% Downside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.